Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-04-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558614000311 |
_version_ | 1818911385061425152 |
---|---|
author | Pradip De Yuling Sun Jennifer H. Carlson Lori S. Friedman Brian R. Leyland-Jones Nandini Dey |
author_facet | Pradip De Yuling Sun Jennifer H. Carlson Lori S. Friedman Brian R. Leyland-Jones Nandini Dey |
author_sort | Pradip De |
collection | DOAJ |
first_indexed | 2024-12-19T22:57:51Z |
format | Article |
id | doaj.art-58c678585f3a4804baf55a9aee07b1bb |
institution | Directory Open Access Journal |
issn | 1476-5586 1522-8002 |
language | English |
last_indexed | 2024-12-19T22:57:51Z |
publishDate | 2014-04-01 |
publisher | Elsevier |
record_format | Article |
series | Neoplasia: An International Journal for Oncology Research |
spelling | doaj.art-58c678585f3a4804baf55a9aee07b1bb2022-12-21T20:02:35ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022014-04-0116437510.1016/j.neo.2014.03.012Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72]Pradip DeYuling SunJennifer H. CarlsonLori S. FriedmanBrian R. Leyland-JonesNandini Deyhttp://www.sciencedirect.com/science/article/pii/S1476558614000311 |
spellingShingle | Pradip De Yuling Sun Jennifer H. Carlson Lori S. Friedman Brian R. Leyland-Jones Nandini Dey Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72] Neoplasia: An International Journal for Oncology Research |
title | Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72] |
title_full | Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72] |
title_fullStr | Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72] |
title_full_unstemmed | Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72] |
title_short | Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014) 43–72] |
title_sort | erratum to doubling down on the pi3k aktmtor pathway enhances the antitumor efficacy of parp inhibitor in triple negative breast cancer model beyond brca ness neoplasia 16 2014 43 72 |
url | http://www.sciencedirect.com/science/article/pii/S1476558614000311 |
work_keys_str_mv | AT pradipde erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372 AT yulingsun erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372 AT jenniferhcarlson erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372 AT lorisfriedman erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372 AT brianrleylandjones erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372 AT nandinidey erratumtodoublingdownonthepi3kaktmtorpathwayenhancestheantitumorefficacyofparpinhibitorintriplenegativebreastcancermodelbeyondbrcanessneoplasia1620144372 |